Equities

Mankind Pharma Ltd

MANKIND:NSI

Mankind Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)2,551.60
  • Today's Change-8.50 / -0.33%
  • Shares traded116.79k
  • 1 Year change+32.02%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 10:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue103,34887,49477,816
OPERATING EXPENSES
Cost of revenue total33,97930,71325,731
Selling, general and admin. expenses, total33,06937,63932,096
Depreciation/amortization3,9823,2591,666
Unusual expense(income)83136(198)
Other operating expenses, total10,844----
Total operating expense81,95771,74759,296
Operating income21,39115,74718,520
Other, net769500121
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes23,99416,71219,746
Provision for income taxes4,5763,6165,216
Net income after taxes19,41813,09714,530
Minority interest(289)(278)(195)
Net income before extra. Items19,12912,81914,335
Total extraordinary items------
Net income19,12912,81914,335
Inc.avail. to common excl. extra. Items19,12912,81914,335
Inc.avail. to common incl. extra. Items19,12912,81914,335
EPS RECONCILIATION
Basic/primary weighted average shares401401401
Basic/primary eps excl. extra items483236
Basic/primary eps incl. extra items483236
Dilution adjustment------
Diluted weighted average shares401401401
Diluted eps excl. extra items483236
Diluted eps incl. extra items483236
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental207365162
SUPPLEMENTAL INCOME
Depreciation, supplemental2,3581,6701,413
Total special items(12)32(229)
NORMALISED INCOME
Normalized income before taxes23,98216,74519,517
Effect of special items on income taxes(2.27)7.02(60)
Income tax excluding impact of special items4,5743,6235,156
Normalized income after tax19,40813,12214,361
Normalized income avail. to common19,11912,84414,167
Basic normalized EPS483235
Diluted normalized EPS483235
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.